Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
Rong Tang, Jin Xu, Wei Wang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101234-101234
Open Access | Times Cited: 20

Showing 20 citing articles:

Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 54
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression
Yuxuan Yang, Xiaokun Liu, Di Yang, et al.
Metabolism (2024) Vol. 155, pp. 155905-155905
Closed Access | Times Cited: 11
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization
Ke Zhang, Jie Zhu, Peng Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 4
CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance
Dijie Zheng, Yazhu Deng, Lu Deng, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin
Qianqian Du, Qianfan Zhang, Jialing Li, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Development of a Nomogram Integrating Modified Inflammation-Based Indexes for Predicting Overall Survival in Pancreatic Cancer: A Retrospective Study
Dailei Qin, Kewei Huang, Zehui Yao, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4813-4830
Open Access
Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy
Jingjing Shi, Xiaoyan Cui, Junlin Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
EPYC functions as a novel prognostic biomarker for pancreatic cancer
Zhen Yang, Honglin Li, Jie Hao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcinoma: a tumor marker prognostic study
Zijin Xu, Jian-ang Li, Ze-yuan Cao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 2
Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study
Zhao Guo, Yuanting Cai, Yuning Wang, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 5
Closed Access | Times Cited: 2
Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer
Qing Wang, Yushuai Yu, Chenxi Wang, et al.
British Journal of Cancer (2024)
Closed Access | Times Cited: 2
Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production
H. J. Yang, Xuhui Tong, Wei Wang, et al.
Cellular Oncology (2024)
Closed Access | Times Cited: 2
Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma
Rong Tang, Zi-Feng Zhang, Jin Xu, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1689-1704
Open Access | Times Cited: 1
Spatial transcriptomics in pancreatic cancer: Advances, prospects and challenges
Yunlong Li, Yongxing Du, Rui Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104430-104430
Open Access | Times Cited: 1
Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era
Xin Xiong, Xin Wang, Cuicui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Shanshan Yang, Miaomiao Lin, Shaodong Hao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Exploring the clinical significance of TPX2 in pancreatic cancer: from biomarker to immunotherapy
Zhengguang Zhang, Zixian Liu, Ying Yao, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Page 1

Scroll to top